C2-C5-Alkyl-imidazole-bisphosphonate s

Details for Australian Patent Application No. 2008328797 (hide)

Owner Novartis AG

Inventors Rondeau, Jean-Michel; Cotesta, Simona; Weiler, Sven; Jahnke, Wolfgang; Widler, Leo

Agent Davies Collison Cave

Pub. Number AU-B-2008328797

PCT Pub. Number WO2009/068567

Priority 07122016.4 30.11.07 EP

Filing date 26 November 2008

Wipo publication date 4 June 2009

Acceptance publication date 3 November 2011

International Classifications

C07F 9/6506 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

A61K 31/663 (2006.01)

A61P 19/00 (2006.01) Drugs for skeletal disorders

Event Publications

15 April 2010 PCT application entered the National Phase

  PCT publication WO2009/068567 Priority application(s): WO2009/068567

3 November 2011 Application Accepted

  Published as AU-B-2008328797

1 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008328805-Compositions for treating an intestinal inflammatory condition

2008328794-Plants having enhanced yield-related traits and a method for making the same